Roswell Park Comprehensive Cancer Center

Roswell Park Comprehensive Cancer Center announced the hiring or promotion of several people across clinical, administrative and research departments.

Several oncology researchers received the NIH Director’s New Innovator Award.

Early cytomegalovirus reactivation after allogeneic stem cell transplantation induced cytomegalovirus antigen-specific T cells that may better prevent future infection, according to results of a retrospective study.

Roswell Park Comprehensive Cancer Center appointed two nursing executives to leadership roles.

Igor Puzanov, MD, MSCI, FACP, has been promoted to senior vice president of clinical investigation at Roswell Park Comprehensive Cancer Center.

Nintedanib appeared safe and effective for the treatment of advanced nonpancreatic neuroendocrine tumors, according to results of a phase 2 study published in Cancer.

Roswell Park Comprehensive Caner Center appointed three staff members within its department of gynecologic oncology to leadership roles.

A clinical trial is underway to assess the safety of a novel immunotherapy combination for the treatment of mild to moderate COVID-19 infection among patients with cancer.

The Society for Immunotherapy of Cancer announced the results of its 2020 election, conducted this spring.

Eunice Wang, MD, has been named medical director of infusion services at Roswell Park Comprehensive Cancer Center.